content: <HTML>
  <HEAD>
  <TITLE></TITLE>
  </HEAD>
  <BODY STYLE="font-size: 10pt">
  
  
  <P STYLE="margin: 0; text-align: center"><B>UNITED STATES</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
  
  <P STYLE="margin: 0; text-align: center">Washington, D.C. 20549</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>FORM 8-K</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>CURRENT REPORT</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>Pursuant to Section 13 or 15(d) of the</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>Securities Exchange Act of 1934</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center">Date of Report (Date of Earliest event Reported):
  July 14, 2014</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center">INTEGRATED INPATIENT TECHNOLOGIES, INC.</P>
  
  <P STYLE="margin: 0; text-align: center">(Exact name of registrant as specified in its
  charter)</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 34%; text-align: center"><B>Nevada</B></TD>
      <TD STYLE="width: 33%; text-align: center"><B>333-191564</B></TD>
      <TD STYLE="width: 33%; text-align: center"><B>65-1011679</B></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center">(State or other jurisdiction of</TD>
      <TD STYLE="text-align: center">(Commission File Number)</TD>
      <TD STYLE="text-align: center">(IRS Employer Identification No.)</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center">incorporation or organization)</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD></TR>
  </TABLE>
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
      <TD STYLE="margin: 0; text-align: center; width: 100%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">100 Linton Boulevard, Suite 213-B</P>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Delray Beach, FL 33483</P></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center">(Address of principal executive offices)</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center">561-276-3737</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center">(Registrant&#8217;s telephone number, including area code)</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center">(Former name or former address, if changed since last report)</TD></TR>
  </TABLE>
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">Check the appropriate box below if the Form
  8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
  (<U>see</U> General Instruction A.2. below):</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
  230.425)</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">[ ] Soliciting material pursuant to Rule
  14a-12 under the Exchange Act (17 CFR 240.14a -12)</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">[ ] Pre-commencement communications
  pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">[ ] Pre-commencement communications pursuant
  to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))</P>
  
  
  <!-- Field: Page; Sequence: 1 -->
      <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin: 0; text-align: justify"><B><U>Item 5.03 Amendment to Articles of Incorporation</U></B></P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">Effective July 16, 2014, the Registrant amended its Articles of
  Incorporation to increase the total number of shares of all classes of stock which the Registrant has the authority to issue to
  310,000,000 shares, of which 300,000,000 shares shall be Common Stock with a par value of $0.0001 per share, and 10,000,000 shares
  shall be Serial Preferred Stock with a par value of $0.0001 per share.</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify"><B><U>Item 5.07. Submission of Matters to a Vote of Security Holders.</U></B></P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">Effective July 14, 2014, the holders of 52.5% of the outstanding
  Common Stock of the Registrant voted to amend the Registrant&#8217;s Articles of Incorporation to increase the total number of
  shares of all classes of stock which the Registrant has the authority to issue to 310,000,000 shares, of which 300,000,000 shares
  shall be Common Stock with a par value of $0.0001 per share, and 10,000,000 shares shall be Serial Preferred Stock with a par
  value of $0.0001 per share.</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify"><B><U>Item 9.01. Financial Statements and Exhibits.</U></B></P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">(d) Exhibits</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify"><A HREF="inpt8k071714ex101.htm"><U>Exhibit 10.1</U></A> Amendment to Articles of Incorporation to increase
  authorized shares.</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify"><B>SIGNATURES</B></P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">Pursuant to the requirements of the Securities Exchange Act of
  1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on the 17th
  day of July 2014.</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
  <TR STYLE="vertical-align: top">
      <TD STYLE="margin: 0; text-align: justify">&nbsp;</TD>
      <TD COLSPAN="3" STYLE="margin: 0; text-align: justify"><B>Integrated Inpatient Solutions, Inc.</B></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="margin: 0; text-align: justify">&nbsp;</TD>
      <TD STYLE="margin: 0; text-align: justify">&nbsp;</TD>
      <TD COLSPAN="2" STYLE="margin: 0; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="margin: 0; text-align: justify; width: 45%">&nbsp;</TD>
      <TD STYLE="margin: 0; text-align: justify; width: 5%">By:&nbsp;&nbsp;</TD>
      <TD STYLE="margin: 0; text-align: justify; width: 39%"><U>/s/ Osnah Bloom</U></TD>
      <TD STYLE="margin: 0; text-align: justify; width: 11%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="margin: 0; text-align: justify">&nbsp;</TD>
      <TD STYLE="margin: 0; text-align: justify">&nbsp;</TD>
      <TD COLSPAN="2"><P STYLE="margin: 0; text-align: justify">Osnah Bloom</P>
          <P STYLE="margin: 0; text-align: justify">Principal Executive Officer and</P>
          <P STYLE="margin: 0; text-align: justify">Principal Financial Officer</P></TD></TR>
  </TABLE>
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
  
  <!-- Field: Page; Sequence: 2; Options: Last -->
      <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="text-align: right; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>
  
  
  </BODY>
  </HTML>
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "inpt8k071714.htm", "secsgml_size_bytes": 8986}]
metadata_filer: {"company-data": {"conformed-name": "Integrated Inpatient Solutions, Inc.", "cik": "0001174672", "assigned-sic": "7389", "irs-number": "000000000", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "333-191564", "film-number": "14981802"}, "business-address": {"street1": "100 LINTON BOULEVARD", "street2": "SUITE 213-B", "city": "DELRAY BEACH", "state": "FL", "zip": "33483", "phone": "561-276-3737"}, "mail-address": {"street1": "100 LINTON BOULEVARD", "street2": "SUITE 213-B", "city": "DELRAY BEACH", "state": "FL", "zip": "33483"}, "former-company": [{"former-conformed-name": "INTEGRATED INPATIENT SOLUTIONS INC", "date-changed": "20131107"}, {"former-conformed-name": "INPATIENT CLINICAL SOLUTIONS INC", "date-changed": "20020603"}]}
text: UNITED STATES
  SECURITIES AND EXCHANGE COMMISSION
  Washington, D.C. 20549
  FORM 8-K
  CURRENT REPORT
  Pursuant to Section 13 or 15(d) of the
  Securities Exchange Act of 1934
  Date of Report (Date of Earliest event Reported):
  July 14, 2014
  INTEGRATED INPATIENT TECHNOLOGIES, INC.
  (Exact name of registrant as specified in its
  charter)
  Nevada
  333-191564
  65-1011679
  (State or other jurisdiction of
  (Commission File Number)
  (IRS Employer Identification No.)
  incorporation or organization)
  100 Linton Boulevard, Suite 213-B
  Delray Beach, FL 33483
  (Address of principal executive offices)
  561-276-3737
  (Registrant's telephone number, including area code)
  (Former name or former address, if changed since last report)
  Check the appropriate box below if the Form
  8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
  (
  see
  General Instruction A.2. below):
  [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
  230.425)
  [ ] Soliciting material pursuant to Rule
  14a-12 under the Exchange Act (17 CFR 240.14a -12)
  [ ] Pre-commencement communications
  pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
  [ ] Pre-commencement communications pursuant
  to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
  Item 5.03 Amendment to Articles of Incorporation
  Effective July 16, 2014, the Registrant amended its Articles of
  Incorporation to increase the total number of shares of all classes of stock which the Registrant has the authority to issue to
  310,000,000 shares, of which 300,000,000 shares shall be Common Stock with a par value of $0.0001 per share, and 10,000,000 shares
  shall be Serial Preferred Stock with a par value of $0.0001 per share.
  Item 5.07. Submission of Matters to a Vote of Security Holders.
  Effective July 14, 2014, the holders of 52.5% of the outstanding
  Common Stock of the Registrant voted to amend the Registrant's Articles of Incorporation to increase the total number of
  shares of all classes of stock which the Registrant has the authority to issue to 310,000,000 shares, of which 300,000,000 shares
  shall be Common Stock with a par value of $0.0001 per share, and 10,000,000 shares shall be Serial Preferred Stock with a par
  value of $0.0001 per share.
  Item 9.01. Financial Statements and Exhibits.
  (d) Exhibits
  Exhibit 10.1
  Amendment to Articles of Incorporation to increase
  authorized shares.
  SIGNATURES
  Pursuant to the requirements of the Securities Exchange Act of
  1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on the 17th
  day of July 2014.
  Integrated Inpatient Solutions, Inc.
  By:
  /s/ Osnah Bloom
  Osnah Bloom
  Principal Executive Officer and
  Principal Financial Officer